Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Coleen Cunningham, MD
Children's Health Center, DUMC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, Uc San Diego Crs- Mother-Child-Adolescent Hiv Program
La Jolla, California, United States
- David Geffen School of Medicine at Ucla Nichd Crs
Los Angeles, California, United States
- Usc la Nichd Crs
Los Angeles, California, United States
- Univ. of Colorado Denver Nichd Crs
Aurora, Colorado, United States
- Lurie Children'S Hospital of Chicago (lch) Crs
Chicago, Illinois, United States
- Rush Univ. Cook County Hosp. Chicago Nichd Crs
Chicago, Illinois, United States
- Johns Hopkins University Center for Immunization Research
Baltimore, Maryland, United States
- Boston Medical Center Ped. Hiv Program Nichd Crs
Boston, Massachusetts, United States
- Suny Stony Brook Nichd Crs
Stony Brook, New York, United States
- Jacobi Med. Ctr. Bronx Nichd Crs
The Bronx, New York, United States
- St. Jude Children'S Research Hospital Crs
Memphis, Tennessee, United States
- Texas Children'S Hospital Crs
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Sept 2017
- Primary completion
- 19 Dec 2019
- Completion
- 1 Oct 2020
- Last update posted
- 22 Apr 2022
- Registered enrollment
- 65
- Registry id
- NCT03227029
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.